Integrated Biopharma INBP
OTC INBP
$0.18 +0.02 (+12.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Integrated Biopharma (INBP) Liabilities from Discontinued Operations (2011)

Updated

Integrated Biopharma (INBP) posted Liabilities from Discontinued Operations of $1.96 million for fiscal Q2 2012 (quarter ended Dec 31, 2011), down 30.6% from the prior quarter.

Analysis

Integrated Biopharma (INBP) Liabilities from Discontinued Operations (2011) Analysis & Trends

At the end of FY2011 (ended Jun 30, 2011), Integrated Biopharma's Liabilities from Discontinued Operations came in at $2.67 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn
10 Integrated Biopharma 5.59 Mn -14.75 Mn 28,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 1.96 Mn
Sep 30, 2011 2.82 Mn
Jun 30, 2011 2.67 Mn
API Access

Integrated Biopharma Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=INBP&period=max&api_key=YOUR_API_KEY